554-75941-04060

4 vaccinations 15 coded responses 32 check-ins 15 free-text entries 3 call cases

Sex: Male
Age at first dose: 36-40
ZIP prefix: 722 / AR
Registered: 2021-01-13

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Dose 1 — Pfizer-BioNTech
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-13
Registered in v-safe
2021-01-13
Survey response — days 1–6 daily, dose 2
MedDRA: Eye pain, Lymphadenopathy, Myalgia, Pain, Visual field defect — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Visual scotoma in last 24h, lymph node swelling under vaccine side arm, ocular muscle pain when looking off of center axis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-15
Health check-in — day 7, dose 2
Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-29
Survey response — day 21, dose 2
MedDRA: Abdominal discomfort, Gastrointestinal pain — Feeling: Fair · Be unable to work

Free text: GI cramping and upset, with no changes in diet or hydration.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — day 28, dose 2
MedDRA: Axillary pain, Breast pain — Feeling: Fair

Free text: Some mild bilateral pain in the breast and underarm area likely lymph nodes, but transient and hard to isolate.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Survey response — 3 months, dose 2
MedDRA: Abdominal discomfort, Arthralgia — Feeling: Fair

Free text: GI upset, generalized cardiothoracic and upper extremity joint pain.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-10
Health check-in — day 7, dose 3
Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-10-15
Survey response — day 14, dose 3
MedDRA: Arthralgia, Immediate post-injection reaction, Pain in extremity — Feeling: Fair

Free text: After subsiding for a week or so post-booster, returning joint pain in ankles, wrists, fingers and elbows similar to that felt in the week immediately following booster dose.

MedDRA releases: 2024-11 · check-in free text available
2021-10-22
Survey response — day 21, dose 3
MedDRA: Abdominal discomfort, Arthralgia, Gastrointestinal pain, Psoriasis — Feeling: Fair

Free text: Joint pain, psoriasis (face), intermittent gi upset and pain.

MedDRA releases: 2024-11 · check-in free text available
2021-10-29
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-11-05
Survey response — day 35, dose 3
MedDRA: Arthralgia, Psoriasis — Feeling: Fair

Free text: Joint pain and psoriasis are worse

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-31
Survey response — 3 months, dose 3
MedDRA: Arthralgia, Dry skin — Feeling: Fair

Free text: Recurring joint pain and dry facial skin patches across forehead and cheeks.

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Survey response — 6 months, dose 3
MedDRA: Arthralgia, Asthenia, Fatigue, Skin exfoliation — Feeling: Fair · Be unable to do your normal daily activities

Free text: Chronic joint pain, general fatigue, scaly psoriatic type patches on face, low energy levels

MedDRA releases: 2024-11 · check-in free text available
2022-10-01
Survey response — 12 months, dose 3
MedDRA: Arthralgia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Frequent joint pain in knees, ankles, elbows, hands. Seems to be random in intensity and location and present on more days than it isn't.

MedDRA releases: 2024-11 · check-in free text available
2022-10-01
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-04
Call 1 — Requested Callback
2022-10-04
Callback requested for
2022-10-06
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-10-07
Call successful
Participant prefers to complete VAERS report online
2022-10-11
Survey response — days 1–6 daily, dose 4
MedDRA: Muscle spasms, Myalgia — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: The night of the injection I had random myalgias that would move throughout my body. As I would change positions to alleviate the cramping, they would move to another muscle bundle. 2-3 sited sites were active at a time for 6 hours.

MedDRA releases: 2024-11 · check-in free text available
2022-10-12
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Diarrhea, Abdominal pain

Adult check-in
2022-10-13
Health check-in — day 7, dose 4
Feeling: Poor · Site: Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2022-10-20
Survey response — day 14, dose 4
MedDRA: Influenza virus test negative, Respiratory disorder, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Unknown respiratory illness. Negative for strep, influenza, and COVID by rapid and PCR testing.

MedDRA releases: 2024-11 · check-in free text available
2022-10-20
Report sent to call center — day 14, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-21
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-27
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-11-03
Survey response — day 28, dose 4
MedDRA: Unevaluable event — Feeling: Fair

Free text: Possible thrush, unsure

MedDRA releases: 2024-11 · check-in free text available
2022-11-12
Survey response — day 35, dose 4
MedDRA: Cough, Oropharyngeal pain — Feeling: Fair

Free text: Chronic sore throat and dry cough

MedDRA releases: 2024-11 · check-in free text available
2022-11-18
Survey response — day 42, dose 4
MedDRA: Cough, Myalgia — Feeling: Fair

Free text: Chronic cough and muscular pain at base of tongue.

MedDRA releases: 2024-11 · check-in free text available
2023-01-05
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No
4	2022-10-06	Pfizer-BioNTech	Flu

Call center

3 call center cases

2 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Visual scotoma in last 24h, lymph node swelling under vaccine side arm, ocular muscle pain when looking off of center axis

Release 3 — day 21, dose 2

2021-01-29

Symptoms: GI cramping and upset, with no changes in diet or hydration.

Release 3 — day 28, dose 2

2021-02-05

Symptoms: Some mild bilateral pain in the breast and underarm area likely lymph nodes, but transient and hard to isolate.

Release 7 — 3 months, dose 2

2021-04-09

Symptoms: GI upset, generalized cardiothoracic and upper extremity joint pain.

Release 10 — day 14, dose 3

2021-10-15

Symptoms: After subsiding for a week or so post-booster, returning joint pain in ankles, wrists, fingers and elbows similar to that felt in the week immediately following booster dose.

Release 10 — day 21, dose 3

2021-10-22

Symptoms: Joint pain, psoriasis (face), intermittent gi upset and pain.

Release 10 — day 35, dose 3

2021-11-05

Symptoms: Joint pain and psoriasis are worse

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Recurring joint pain and dry facial skin patches across forehead and cheeks.

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Chronic joint pain, general fatigue, scaly psoriatic type patches on face, low energy levels

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: Frequent joint pain in knees, ankles, elbows, hands. Seems to be random in intensity and location and present on more days than it isn't.

Release 12 — days 1–6 daily, dose 4

2022-10-11

Systemic reaction (other): The night of the injection I had random myalgias that would move throughout my body. As I would change positions to alleviate the cramping, they would move to another muscle bundle. 2-3 sited sites were active at a time for 6 hours.

Release 12 — day 14, dose 4

2022-10-20

Symptoms: Unknown respiratory illness. Negative for strep, influenza, and COVID by rapid and PCR testing.

Release 12 — day 28, dose 4

2022-11-03

Symptoms: Possible thrush, unsure

Release 12 — day 35, dose 4

2022-11-12

Symptoms: Chronic sore throat and dry cough

Release 12 — day 42, dose 4

2022-11-18

Symptoms: Chronic cough and muscular pain at base of tongue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal discomfort	✓	✓	✓
SD	Arthralgia	✓	✓	✓
SD	Asthenia	·	·	✓
SD	Axillary pain	✓	✓	✓
SD	Breast pain	✓	✓	✓
SD	Cough	·	·	✓
SD	Dry skin	·	·	✓
SD	Fatigue	·	·	✓
SD	Gastrointestinal pain	✓	✓	✓
SD	Immediate post-injection reaction	·	·	✓
SD	Influenza virus test negative	·	·	✓
SD	Myalgia	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Psoriasis	·	·	✓
SD	Respiratory disorder	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Skin exfoliation	·	·	✓
SD	Unevaluable event	·	·	✓
SRO	Eye pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Muscle spasms	·	·	✓
SRO	Myalgia	✓	✓	✓
SRO	Pain	✓	✓	✓
SRO	Visual field defect	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release